Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. März 2026 18:25 ET | Quelle: Hagens Berman Sobol Shapiro LLP

CORT INVESTOR ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
11. März 2026 11:00 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
09. März 2026 12:01 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
06. März 2026 14:17 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
04. März 2026 13:28 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
02. März 2026 11:56 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
27. Februar 2026 13:58 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts CORT Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
23. Februar 2026 14:22 ET | Quelle: Hagens Berman Sobol Shapiro LLP

Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline

Investors who lost money in CORT after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
30. Januar 2026 11:27 ET | Quelle: Bernstein Liebhard LLP

CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
30. Januar 2026 10:13 ET | Quelle: Block & Leviton LLP

Corcept Therapeutics Investigated for Securities Fraud Following Report of FDA Warnings; Shareholders Should Contact Block & Leviton To Recover Losses

Corcept Therapeutics (CORT) under investigation following report of previous FDA warnings. Block & Leviton encourages investors to contact the firm.

Nächste Seite